image_pdfimage_print

Author Archives: europa - newsroom

ESMA updates EMIR Q&A

The Q&As clarify: OTC Question 2(h) on when counterparties that start taking positions in OTC derivatives need to notify the relevant NCAs and ESMA; OTC Question 4 on whether counterparties not subject to the clearing obligation should also obtain … read more